Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique

Reference

• Crane FL. (2001). Biochemical functions of coenzyme Q10. J Am Coll Nutr, 20:591–598.
   PubMed Web of Science ®Google Scholar
• Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S. (1999). Coenzyme Q10 in health and disease. Eur J Clin Nutr, 53:764–770.
   PubMed Web of Science ®Google Scholar
• Quinzii CM, DiMauro S, Hirano M. (2007). Human coenzyme Q10 deficiency. Neurochem Res, 32:723–727.
   PubMed Web of Science ®Google Scholar
• Hoppe U, Bergemann J, Diembeck W, Ennen J, Gohla S, Harris I et al. (1999). Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors, 9:371–378.
   PubMed Web of Science ®Google Scholar
• Mason TG, Wilking J, Meleson K, Chang C,Graves S. (2006). Nanoemulsions: formation, structure, and physical properties. J Phys Condens Matter, 18: R635.
   Web of Science ®Google Scholar
• Cevc G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev, 56:675–711.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 4:145–160.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm, 366:170–184.
   PubMed Web of Science ®Google Scholar
• Shah JC, Sadhale Y, Chilukuri DM. (2001). Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev, 47:229–250.
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. (2000). Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm, 199:167–177.
   PubMed Web of Science ®Google Scholar
• Radtke M, Müller RH. (2001). NLC–nanostructured lipid carriers: the new generation of lipid drug carriers. New Drugs, 2: 48–52.
   Google Scholar
• Bhaskar K, Krishna Mohan C, Lingam M, Prabhakar Reddy V, Venkateswarlu V, Madhusudan Rao Y. (2008). Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization. Drug Dev Ind Pharm, 34:719–725.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm, 242:121–128.
   PubMed Web of Science ®Google Scholar
• Souto E, Almeida A, Müller RH(2007). Lipid nanoparticles (SLN, NLC) for cutaneous drug delivery: structure, protection and skin Effects. J Biomed Nanotech, 3: 317–331.
   Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 54 Suppl 1:S131–S155.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH. (2008). Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm, 34:1394–1405.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting M, Mehnert W, Korting HC. (2007). Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev, 59:427–443.
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Du D, Liu W, Liu J, Weng T et al. (2006). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release, 110:296–306.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. (2007). Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm, 328:191–195.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. (2000). Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm, 49:211–218.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–618.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Müller RH. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm, 278:71–77.
   PubMed Web of Science ®Google Scholar
• Vemuri S, Yu CD, Wangsatorntanakun V, Roosdorp N. (1990). Large-scale production of liposomes by a microfluidizer. Drug Dev Ind Pharm, 16:2243–2256.
   Web of Science ®Google Scholar
• Dragicevic-Curic N, Winter S, Stupar M, Milic J, Krajisnik D, Gitter B et al. (2009). Temoporfin-loaded liposomal gels: viscoelastic properties and in vitro skin penetration. Int J Pharm, 373:77–84.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev, 47:165–196.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. (2007). Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm, 67:141–148.
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhao J, Zhang X, Pan W. (2011). Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm, 403:185–191.
   PubMed Web of Science ®Google Scholar
• Liu W, Hu M, Liu W, Xue C, Xu H, Yang X. (2008). Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm, 364:135–141.
   PubMed Web of Science ®Google Scholar
• Moddaresi M, Brown MB, Zhao Y, Tamburic S, Jones SA. (2010). The role of vehicle-nanoparticle interactions in topical drug delivery. Int J Pharm, 400:176–182.
   PubMed Web of Science ®Google Scholar
• Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W et al. (2011). Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev, 63:470–491.
   PubMed Web of Science ®Google Scholar
• Müller RH, Petersen RD, Hommoss A, Pardeike J. (2007). Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev, 59:522–530.
   PubMed Web of Science ®Google Scholar
• de Vringer T, de Ronde HA. (1995). Preparation and structure of a water-in-oil cream containing lipid nanoparticles. J Pharm Sci, 84:466–472.
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. (2009). Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm, 71:161–172.
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev, 56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Wu L, Tang C, Yin C. (2010). Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm, 36:439–448.
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. (2003). Physico-chemical stability of colloidal lipid particles. Biomaterials, 24:4283–4300.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Müller RH, Keck CM. (2011). Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement. Drug Dev Ind Pharm, 37:8–14.
   PubMed Web of Science ®Google Scholar